Jun 4, 2026
Testosterone replacement therapy suppresses sperm production in the majority of men, often to levels incompatible with natural conception. This effect is caused by the suppression of the hypothalamic-pituitary-gonadal (HPG) axis: exogenous testosterone shuts down the FSH and LH signals that drive spermatogenesis in the testes. The suppression is typically reversible after stopping TRT, but recovery […]
May 31, 2026
Neither testosterone pellets nor injections are universally superior — the better choice depends on the individual patient’s lifestyle, tolerance for hormonal fluctuation, cost constraints, and fertility considerations. Injections offer precise dose control, easy adjustment, and lowest cost. Pellets offer convenience and stable levels without weekly administration. Both deliver therapeutic testosterone effectively in confirmed hypogonadism, but […]
May 26, 2026
TRT costs in 2026 range from approximately $30 per month for generic injectable testosterone to over $1,200 per pellet insertion, depending on formulation, provider type, and insurance coverage. Medication is only one component: lab work, physician visits, and supplies add $100 to $400 per month on top of the drug cost in a typical self-pay […]
May 19, 2026
Testosterone replacement therapy improves erectile function in men with confirmed hypogonadism, but it is not a universal treatment for erectile dysfunction. Clinical evidence shows that TRT restores erectile function reliably in men whose ED is caused by testosterone deficiency. In men with normal testosterone, TRT adds little benefit. The key clinical question is not whether […]
May 14, 2026
Low testosterone in men produces a recognizable cluster of symptoms across physical, sexual, and psychological domains. The 15 signs listed here are derived from clinical diagnostic criteria used by the Endocrine Society and reflect the most consistently reported symptoms in hypogonadism research. No single symptom confirms low testosterone. The diagnosis requires laboratory confirmation on at […]
May 10, 2026
Oral semaglutide (Rybelsus) is FDA-approved for type 2 diabetes but not for chronic weight management. The injectable form (Wegovy, 2.4mg weekly) is the only FDA-approved semaglutide formulation for weight loss. Rybelsus produces approximately 4.4% body weight reduction vs. 14.9% with Wegovy in clinical data, primarily because oral bioavailability of semaglutide is approximately 1% compared to […]
May 4, 2026
Tirzepatide (Zepbound) produces greater average weight loss than semaglutide (Wegovy) in head-to-head trial data. The SURMOUNT-5 trial (2025) found tirzepatide reduced body weight by approximately 20.2% vs. 13.7% for semaglutide over 72 weeks. Both are FDA-approved injectable medications for chronic weight management, but they work through different receptor mechanisms, follow different dosing schedules, and carry […]
May 1, 2026
Depression and low testosterone are clinically connected in both directions. Testosterone acts on androgen receptors in limbic and prefrontal brain regions that regulate mood, motivation, and stress response. Deficiency in these pathways produces depressive symptoms that are often indistinguishable from primary major depressive disorder. At the same time, depression itself suppresses testosterone production through the […]
Apr 24, 2026
TRT withdrawal refers to the cluster of symptoms that occur after stopping testosterone replacement therapy, caused by suppression of the body’s natural testosterone production during treatment. Common symptoms include fatigue, low mood, reduced libido, and muscle loss — and they persist until the hypothalamic–pituitary–gonadal (HPG) axis recovers and endogenous testosterone production resumes. Recovery typically takes […]
Apr 19, 2026
TRT withdrawal refers to the cluster of symptoms that occur after stopping testosterone replacement therapy, caused by suppression of the body’s natural testosterone production during treatment. Common symptoms include fatigue, low mood, reduced libido, and muscle loss — and they persist until the hypothalamic–pituitary–gonadal (HPG) axis recovers and endogenous testosterone production resumes. Recovery typically takes […]
Apr 16, 2026
Semaglutide and alcohol — the combination is more complex than most patients are told. It’s not a straightforward contraindication — semaglutide doesn’t cause a dangerous reaction with alcohol the way some medications do. But the interaction affects tolerability, blood sugar stability, cardiovascular risk, and in some patients, the desire to drink at all. This guide […]
Apr 11, 2026
Stopping testosterone replacement therapy without a plan is not a clinical strategy, it’s a risk. Whether you’re pausing treatment to conceive, reassessing long-term therapy, or managing side effects, coming off TRT requires a structured tapering protocol and physician oversight. This guide covers the clinical steps, what your body goes through, and how to protect your […]
Feel Young Again.
Reverse Low-T Symptoms With TRT
